|
|||||
|
|
||||||
JCO Early Release, published online ahead of print Jan 26 2009
Received August 23, 2008 Safety of Ovarian Preservation in Premenopausal Women With Endometrial Cancer
From the Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, and Department of Radiation Oncology, Columbia University College of Physicians and Surgeons; and Herbert Irving Comprehensive Cancer Center, New York, NY. * To whom correspondence should be addressed. E-mail: jw2459{at}columbia.edu
Purpose: Oophorectomy is commonly performed in premenopausal women with endometrial cancer who undergo hysterectomy. The benefits of oophorectomy in this setting are unknown, and the procedure subjects women to the long-term sequelae of estrogen deprivation. We examined the safety of ovarian preservation in young women with endometrial cancer who underwent hysterectomy. Patients and Methods: Women Results: A total of 3,269 women, including 402 patients (12%) who had ovarian preservation, were identified. Younger age (P < .0001), later year of diagnosis (P = .04), residence in the eastern United States (P = .02), and low tumor grade (P < .0001) were associated with ovarian preservation. In a multivariate Cox model, ovarian preservation had no effect on either cancer-specific (hazard ratio [HR] = 0.58; 95% CI, 0.14 to 2.44) or overall (HR = 0.68; 95% CI, 0.34 to 1.35) survival. The findings were unchanged when women who received pelvic radiotherapy were excluded. Conclusion: Ovarian preservation in premenopausal women with early-stage endometrial cancer may be safe and not associated with an increase in cancer-related mortality.
|
|
|||||||||||
|
Copyright © 2009 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|